Valeant Pharmaceuticals reported $391M in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Aphria Inc APH:CN C$ -353810000 214.73M
Aurora Cannabis Inc ACB:CN -12092000 126.76M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Canopy Growth Corp WEED:CN C$ -19538000 412.39M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Supernus Pharmaceuticals SUPN:US $ 28.96M 2.28M
Zoetis ZTS:US $ 717M 11M